Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Volcano has announced its participation in Saturn clinical trial sponsored by AstraZeneca. This marks the major pharmaceutical trial allowing physicians to use the Volcano Revolution 45 MHz IVUS Imaging catheter as part of the protocol.
Subscribe to our email newsletter
Saturn is a 104-week, parallel-group, multicentre, double-blind, Phase IIIb intravascular ultrasound (IVUS) imaging study of approximately 1,300 patients at 170 centres worldwide. This study by AstraZeneca is designed to measure the impact of Crestor 40mg and atorvastatin (Lipitor) 80mg on the progression of atherosclerosis in high risk patients.
Saturn will compare the effects of these two statins on the ability to decrease progression or induce regression of atherosclerosis, the main cause of cardiovascular disease, following two years of treatment in patients with coronary artery disease.